BIOYF
Price
$8.20
Change
-$0.00 (-0.00%)
Updated
Aug 15 closing price
Capitalization
93.29M
BKUH
Price
$0.02
Change
+$0.01 (+100.00%)
Updated
Jun 10 closing price
Capitalization
6.03M
Interact to see
Advertisement

BIOYF vs BKUH

Header iconBIOYF vs BKUH Comparison
Open Charts BIOYF vs BKUHBanner chart's image
BioSyent
Price$8.20
Change-$0.00 (-0.00%)
Volume$10.54K
Capitalization93.29M
Bakhu Holdings
Price$0.02
Change+$0.01 (+100.00%)
Volume$500
Capitalization6.03M
BIOYF vs BKUH Comparison Chart in %
Loading...
BIOYF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BKUH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BIOYF vs. BKUH commentary
Aug 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BIOYF is a StrongBuy and BKUH is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 18, 2025
Stock price -- (BIOYF: $8.20 vs. BKUH: $0.02)
Brand notoriety: BIOYF and BKUH are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: BIOYF: 722% vs. BKUH: 100%
Market capitalization -- BIOYF: $93.29M vs. BKUH: $6.03M
BIOYF [@Pharmaceuticals: Generic] is valued at $93.29M. BKUH’s [@Pharmaceuticals: Generic] market capitalization is $6.03M. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $68.3B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.74B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BIOYF’s FA Score shows that 2 FA rating(s) are green whileBKUH’s FA Score has 1 green FA rating(s).

  • BIOYF’s FA Score: 2 green, 3 red.
  • BKUH’s FA Score: 1 green, 4 red.
According to our system of comparison, BIOYF is a better buy in the long-term than BKUH.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BIOYF’s TA Score shows that 4 TA indicator(s) are bullish while BKUH’s TA Score has 1 bullish TA indicator(s).

  • BIOYF’s TA Score: 4 bullish, 5 bearish.
  • BKUH’s TA Score: 1 bullish, 0 bearish.
According to our system of comparison, BKUH is a better buy in the short-term than BIOYF.

Price Growth

BIOYF (@Pharmaceuticals: Generic) experienced а -1.13% price change this week, while BKUH (@Pharmaceuticals: Generic) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +6.26%. For the same industry, the average monthly price growth was +68.76%, and the average quarterly price growth was +80.82%.

Industries' Descriptions

@Pharmaceuticals: Generic (+6.26% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BIOYF($93.3M) has a higher market cap than BKUH($6.03M). BKUH YTD gains are higher at: 33.333 vs. BIOYF (7.242).
BIOYFBKUHBIOYF / BKUH
Capitalization93.3M6.03M1,548%
EBITDA11.3MN/A-
Gain YTD7.24233.33322%
P/E Ratio16.88N/A-
Revenue38.3MN/A-
Total Cash17.4MN/A-
Total Debt990KN/A-
FUNDAMENTALS RATINGS
BIOYF vs BKUH: Fundamental Ratings
BIOYF
BKUH
OUTLOOK RATING
1..100
5027
VALUATION
overvalued / fair valued / undervalued
1..100
26
Undervalued
10
Undervalued
PROFIT vs RISK RATING
1..100
33100
SMR RATING
1..100
42100
PRICE GROWTH RATING
1..100
5754
P/E GROWTH RATING
1..100
54100
SEASONALITY SCORE
1..100
3955

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BKUH's Valuation (10) in the null industry is in the same range as BIOYF (26). This means that BKUH’s stock grew similarly to BIOYF’s over the last 12 months.

BIOYF's Profit vs Risk Rating (33) in the null industry is significantly better than the same rating for BKUH (100). This means that BIOYF’s stock grew significantly faster than BKUH’s over the last 12 months.

BIOYF's SMR Rating (42) in the null industry is somewhat better than the same rating for BKUH (100). This means that BIOYF’s stock grew somewhat faster than BKUH’s over the last 12 months.

BKUH's Price Growth Rating (54) in the null industry is in the same range as BIOYF (57). This means that BKUH’s stock grew similarly to BIOYF’s over the last 12 months.

BIOYF's P/E Growth Rating (54) in the null industry is somewhat better than the same rating for BKUH (100). This means that BIOYF’s stock grew somewhat faster than BKUH’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BIOYFBKUH
RSI
ODDS (%)
Bullish Trend 3 days ago
48%
N/A
Stochastic
ODDS (%)
Bullish Trend 3 days ago
50%
N/A
Momentum
ODDS (%)
Bullish Trend 3 days ago
49%
N/A
MACD
ODDS (%)
Bearish Trend 3 days ago
47%
N/A
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
38%
Bullish Trend 3 days ago
39%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
40%
Bullish Trend 3 days ago
38%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
Bearish Trend 3 days ago
42%
N/A
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
55%
N/A
Aroon
ODDS (%)
Bearish Trend 3 days ago
43%
Bullish Trend 3 days ago
49%
View a ticker or compare two or three
Interact to see
Advertisement
BIOYF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BKUH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
OMAB106.892.97
+2.86%
Grupo Aeroportuario del Centro Norte S.A.B. de C.V. ADS
OPK1.370.02
+1.48%
OPKO Health
KTCC2.78-0.01
-0.36%
Key Tronic Corp
RACE460.55-3.88
-0.84%
Ferrari NV
SLN5.49-0.15
-2.58%
Silence Therapeutics Plc

BIOYF and

Correlation & Price change

A.I.dvisor tells us that BIOYF and AVCNF have been poorly correlated (+9% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BIOYF and AVCNF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BIOYF
1D Price
Change %
BIOYF100%
-0.05%
AVCNF - BIOYF
9%
Poorly correlated
-2.28%
BUDZ - BIOYF
7%
Poorly correlated
-13.11%
BIOVF - BIOYF
7%
Poorly correlated
N/A
BIOGY - BIOYF
1%
Poorly correlated
N/A
BKUH - BIOYF
-1%
Poorly correlated
N/A
More

BKUH and

Correlation & Price change

A.I.dvisor tells us that BKUH and HSTI have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BKUH and HSTI's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BKUH
1D Price
Change %
BKUH100%
N/A
HSTI - BKUH
25%
Poorly correlated
N/A
BSPK - BKUH
8%
Poorly correlated
N/A
BUDZ - BKUH
2%
Poorly correlated
-13.11%
BIOGY - BKUH
1%
Poorly correlated
N/A
AVCNF - BKUH
0%
Poorly correlated
-2.28%
More